The
The European Vaccine Initiative (EVI) is a leading European, non-profit Product Development Partnership (PDP) specializing in the development of safe, effective and affordable vaccines for neglected poverty-related diseases and emerging infectious diseases. Since its founding in 1998, EVI has worked as a science-driven organization in close collaboration with a global network of over 200 partners from research institutions, the public and private sectors, and civil society organizations to advance innovative solutions in vaccine research and development[2][3][4][6].
The main mission of EVI is to develop new vaccines for global health through coordinated collaboration, thereby ensuring access to effective and affordable vaccines worldwide. EVI pursues a vision in which vaccines create health and equal opportunities for all people, thereby sustainably eliminating the immense burden of diseases of poverty[4].
The company bundles its activities into three core areas:
As part of its values, EVI is consistently committed to the United Nations' Sustainable Development Goals (SDGs), particularly in the areas of good health and well-being, education, poverty reduction and equal opportunities. Immunization is understood as a key to improving the quality of life, as it prevents disease, reduces poverty and promotes access to education and productivity. EVI sees vaccines as a central element for social and health justice worldwide[4].
In addition, EVI is an active member and coordinator of important European projects such as TRANSVAC, which promotes the development of vaccines through networking and resource management. The organization, based in Heidelberg, Germany, brings many years of experience in coordinating large research initiatives funded by the EU and other donors, thus guaranteeing efficient project implementation and collaborative partnerships[2].
Sustainability and social responsibility are the focus at EVI: By promoting affordable vaccines for neglected diseases, the initiative makes a significant contribution to global health security and poverty reduction. The organization also supports the development of new methods, such as non-animal testing methods, to test vaccine quality in an environmentally conscious manner and thus promote ethical standards and sustainability in biomedical research[3].
Overall, the European Vaccine Initiative sees itself as an innovative catalyst that drives European and global vaccine development through scientific excellence, collaborative cooperation and future-oriented strategies to address the pressing global health challenges and create a more just world without diseases of poverty.
